Danuglipron demonstrated mean placebo-adjusted weight reductions ranging from -8% to -13% at 32 weeks and -5% to -9.5% at 26 weeks While most common adv...
ReWalk Robotics, Ltd. (Nasdaq: RWLK) ("ReWalk" or the "Company"), a leading provider of innovative technologies that enable mobility and wellness in r...
Key apps from the iCAD Breast Health Suite are now integrated with GE HealthCare’s new MyBreastAI Suite* AI applications streamline workflow and s...
Proof of Concept – Evaxion’s AI-Immunology™ platform demonstrates success in designing precision cancer vaccines in hematological cance...
Successful First Implants in Spain, Accelerating Market Penetration New Approvals in Colombia and Indonesia Boost Sales Prospects Spineway Advances as ...
SciSparc’s novel SCI-210 therapy is not only a medication based on CBD; it is also a unique combination of cannabidiol (CBD) and SciSparc's proprieta...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced that it has filed for orphan ...
A wave of respiratory illnesses, accompanied by alarming clusters of pneumonia cases, has inundated hospitals in northern China, sparking deep concerns abo...
Partnership agreement signed on 22 November to broaden distribution and promotion of cough and cold brands such as Shidagong, Gelite and Ruike in China&n...
The Dementia Discovery Fund (DDF), a SV Health Investors (SV) fund specialized in pursuing transformational therapeutic approaches for dementias including ...
Wipro Limited a leading technology services and consulting company, today announced a collaboration with NVIDIA to help healthcare companies accelera...
Genomic medicine, also known as precision medicine, offers transformative opportunities to reshape health care and public health from a 'one size fits all'...
ABC Medical, a behavioral healthcare start-up, headquartered in Reading, Massachusetts, wants to offer an alternative – a comprehensive treatment pro...
The SOPHIE program supports collaborative projects for Ontario-based life science firms in the later stages of commercialization. DiagnaMed can leverage fu...
© 2025 Biopharma Boardroom. All Rights Reserved.
